XW0E33BIntroduction of Lunsotogene Parvec-cwha via Intracochlear Infusion into Ear(s), Percutaneous Approach, New Technology Group 11

New Technology›Anatomical Regions›Introduction
ICD-10-PCS XW0E33B
CMS Source: FY 2027 ICD-10-PCS dataset. Effective Oct 1, 2026 – Sep 30, 2027.FacebookXLinkedInPrint

XW0E33B is a billable ICD-10-PCS procedure code for Introduction of Lunsotogene Parvec-cwha via Intracochlear Infusion into Ear(s), Percutaneous Approach, New Technology Group 11. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products. The Alphabetic Index lists this code under Lunsotogene Parvec-cwha via Intracochlear Infusion.

Code Identity

ICD-10-PCS Code
XW0E33B
Billable Status
Yes — Valid for Submission
Code Describes
Introduction of Lunsotogene Parvec-cwha via Intracochlear Infusion into Ear(s), Percutaneous Approach, New Technology Group 11
Short Description
Introduce Lunstgen Parvec in Ear(s), Perc, New Tech 11
Parent Code
XW0

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1SectionXNew Technology
2Body SystemWAnatomical Regions
3Operation0Introduction
4BodyPartEEar(s)
5Approach3Percutaneous
6Device/Substance/Technology3Lunsotogene Parvec-cwha via Intracochlear Infusion
7QualifierBNew Technology Group 11

In the ICD-10-PCS Alphabetic Index

The FY 2027 ICD-10-PCS Alphabetic Index refers to XW0E33B as Lunsotogene Parvec-cwha via Intracochlear Infusion. These index entries lead to this code:

Lunsotogene Parvec-cwha via Intracochlear Infusion
Direct entry for this code
New Technology, Lunsotogene Parvec-cwha via Intracochlear Infusion
Direct entry for this code
Iloprost
Leads to this code's table
Otarmeni(tm)
Anatomy or device term that leads here
Sarilumab
Leads to this code's table
Posoleucel
Leads to this code's table
Rezafungin
Leads to this code's table
Treosulfan
Leads to this code's table
Baricitinib
Leads to this code's table
Sabizabulin
Leads to this code's table
Tocilizumab
Leads to this code's table
Caplacizumab
Leads to this code's table
COVID-19 Vaccine
Leads to this code's table
Inebilizumab-cdon
Leads to this code's table
Lunsotogene Parvec
Anatomy or device term that leads here

To code lunsotogene parvec-cwha via intracochlear infusion, open the FY 2027 ICD-10-PCS Alphabetic Index at Lunsotogene Parvec-cwha via Intracochlear Infusion. The entry lists XW0E33B directly as a complete, billable code.

Browse the full ICD-10-PCS Alphabetic Index →

Code History

FY 2027New code, effective October 1, 2026.
Replaces previously assigned code(s):
  • 3E0B3GC — Introduction of Oth Therap Subst into Ear, Perc Approach

Questions About XW0E33B

Is XW0E33B a billable code?

Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Lunsotogene Parvec-cwha via Intracochlear Infusion into Ear(s), Percutaneous Approach, New Technology Group 11 on inpatient claims from October 1, 2026 through September 30, 2027.

What is the ICD-10-PCS code for lunsotogene Parvec-cwha via Intracochlear Infusion?

The ICD-10-PCS Alphabetic Index lists Lunsotogene Parvec-cwha via Intracochlear Infusion under code XW0E33B, Introduction of Lunsotogene Parvec-cwha via Intracochlear Infusion into Ear(s), Percutaneous Approach, New Technology Group 11, billable on inpatient claims in fiscal year 2027.

What do the characters in XW0E33B mean?

The code breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character E is the BodyPart (Ear(s)); the 5th character 3 is the Approach (Percutaneous); the 6th character 3 is the Device/Substance/Technology (Lunsotogene Parvec-cwha via Intracochlear Infusion); the 7th character B is the Qualifier (New Technology Group 11).